Stoke Therapeutics (STOK) Interest Coverage Ratio (2025 - 2026)
Stoke Therapeutics' quarterly Interest Coverage Ratio came in at 2322.52 in Q1 2026, down 102.09% year-on-year from 111240.0 in Q1 2025, and down 102.09% quarter-over-quarter from 111240.0 in Q1 2025.
Stoke Therapeutics has reported Interest Coverage Ratio for 2 years, with the latest figure at 2322.52 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | -2,322.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,322.52 |
| Mar 31, 2025 | 111,240.00 |